Literature DB >> 8069707

Nigral type I astrocytes release a soluble factor that increases dopaminergic neuron survival through mechanisms distinct from basic fibroblast growth factor.

E K O'Malley1, B A Sieber, R S Morrison, I B Black, C F Dreyfus.   

Abstract

Our studies have been directed to the identification of local, naturally-occurring molecules that support substantia nigra (SN) dopaminergic (DA) neuron survival. We have previously demonstrated that local Type I astrocytes selectively increase the dopaminergic population [30,31]. However, the mechanism of action remains to be defined. To determine whether survival is elicited through diffusible agents, Type I astrocyte conditioned medium (CM) was tested on SN dissociates. After 7 days of exposure to CM, DA neuronal integrity was monitored immunocytochemically with antibody to tyrosine hydroxylase (TH), the DA biosynthetic enzyme, or by TH catalytic assay. CM increased TH+ cell number greater than 2-fold, suggesting that a soluble factor(s) promoted neuron survival. Neurons cultured in serum free medium (SFM) are known to contain few, but detectable numbers of glia [34]. To examine whether CM affected neurons directly, or indirectly through glia, glial populations were stained with antibody against the glial marker, glial fibrillary acidic protein (GFAP). We employed several approaches to define the potential role of glia. Initially, CM was compared to basic fibroblast growth factor (bFGF), a glial mitogen that reportedly enhances nigral DA neuron survival. bFGF enhanced TH activity in our system, as well, but the effect was blocked by the mitotic inhibitor 5-fluorodeoxyuridine (FDUR), which kills dividing glia. In parallel studies CM increased enzyme activity and TH cell number in cultures exhibiting GFAP+ cells. To define the role of these glial cells in the CM effect, we completely eliminated astrocytes in CM-treated cultures employing alpha-aminoadipic acid (AA; 10-30 microM), a specific gliotoxin. At a concentration of AA that eliminated detectable GFAP+ cells, CM continued to elicit a significant increase in TH cell number. These data suggest that, in contrast to effects of bFGF, the DA neurotrophic activity in CM acts directly on nigral neurons to enhance survival.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8069707     DOI: 10.1016/0006-8993(94)91401-x

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  9 in total

1.  An immortalized, type-1 astrocyte of mesencephalic origin source of a dopaminergic neurotrophic factor.

Authors:  D M Panchision; P A Martin-DeLeon; T Takeshima; J M Johnston; K Shimoda; P Tsoulfas; R D McKay; J W Commissiong
Journal:  J Mol Neurosci       Date:  1998-12       Impact factor: 3.444

2.  Increased vulnerability to L-DOPA toxicity in dopaminergic neurons From VMAT2 heterozygote knockout mice.

Authors:  Shingo Kariya; Nobuyuki Takahashi; Makito Hirano; Satoshi Ueno
Journal:  J Mol Neurosci       Date:  2005       Impact factor: 3.444

3.  Sonic hedgehog facilitates dopamine differentiation in the presence of a mesencephalic glial cell line.

Authors:  N Matsuura; D C Lie; M Hoshimaru; M Asahi; M Hojo; R Ishizaki; N Hashimoto; S Noji; H Ohuchi; H Yoshioka; F H Gage
Journal:  J Neurosci       Date:  2001-06-15       Impact factor: 6.167

4.  Systematic differences in time of dopaminergic neuron origin between normal mice and homozygous weaver mutants.

Authors:  S A Bayer; K V Wills; L C Triarhou; J D Thomas; B Ghetti
Journal:  Exp Brain Res       Date:  1995       Impact factor: 1.972

5.  Null mutation of c-fos causes exacerbation of methamphetamine-induced neurotoxicity.

Authors:  X Deng; B Ladenheim; L I Tsao; J L Cadet
Journal:  J Neurosci       Date:  1999-11-15       Impact factor: 6.167

6.  Neuronal expression of zinc finger transcription factor REST/NRSF/XBR gene.

Authors:  K Palm; N Belluardo; M Metsis; T Timmusk
Journal:  J Neurosci       Date:  1998-02-15       Impact factor: 6.167

7.  MANF: a new mesencephalic, astrocyte-derived neurotrophic factor with selectivity for dopaminergic neurons.

Authors:  Penka Petrova; Andrei Raibekas; Jonathan Pevsner; Noel Vigo; Mordechai Anafi; Mary K Moore; Amy E Peaire; Viji Shridhar; David I Smith; John Kelly; Yves Durocher; John W Commissiong
Journal:  J Mol Neurosci       Date:  2003-04       Impact factor: 3.444

8.  Effect of TO901317 on GF to promote the differentiation of human bone marrow mesenchymal stem cells into dopamine neurons on Parkinson's disease.

Authors:  Miaomiao Li; Junqing Yang; Oumei Cheng; Zhe Peng; Yin Luo; Dongzhi Ran; Yang Yang; Pu Xiang; Haifeng Huang; Xiaodan Tan; Hong Wang
Journal:  Ther Adv Chronic Dis       Date:  2021-03-19       Impact factor: 5.091

9.  Region-Specific Neuroprotective Features of Astrocytes against Oxidative Stress Induced by 6-Hydroxydopamine.

Authors:  Masato Asanuma; Nao Okumura-Torigoe; Ikuko Miyazaki; Shinki Murakami; Yoshihisa Kitamura; Toshiaki Sendo
Journal:  Int J Mol Sci       Date:  2019-01-30       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.